MoneyWorks4Me

Divi’s Laboratories informs about conference call

25 Jan 2023 Evaluate

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, Divi’s Laboratories has informed that it enclosed the schedule of earnings conference call for Q3FY23 to be held on February 03, 2023.

The above information is a part of company’s filings submitted to BSE.


Peers
Company Name CMP
Sun Pharma. Inds. 1759.10
Dr. Reddys Labs. 1230.50
Cipla 1313.70
Lupin 1946.00
Zydus Lifesciences 1139.00
View more..